A5008196246- Angiogenesis and VEGF in Cancer
- Cancer, Lipids, and Metabolism
- Ovarian cancer diagnosis and treatment
- Prostate Cancer Treatment and Research
- Breast Lesions and Carcinomas
- Intraperitoneal and Appendiceal Malignancies
- Chemokine receptors and signaling
- Gastric Cancer Management and Outcomes
- Immunotherapy and Immune Responses
- Cleft Lip and Palate Research
- Cancer Mechanisms and Therapy
- Sarcoma Diagnosis and Treatment
- Birth, Development, and Health
- Prenatal Screening and Diagnostics
- Pregnancy and preeclampsia studies
- Renal and Vascular Pathologies
- Hernia repair and management
- Cancer Cells and Metastasis
- Congenital Anomalies and Fetal Surgery
- Vascular anomalies and interventions
- Colorectal and Anal Carcinomas
- Gestational Diabetes Research and Management
- Inflammatory mediators and NSAID effects
- Shoulder and Clavicle Injuries
- Cancer, Stress, Anesthesia, and Immune Response
Vall d'Hebron Hospital Universitari
2021-2025
Universitat Autònoma de Barcelona
2021
University Hospital Complex Of Vigo
2012-2015
Universidade de Vigo
2015
Complejo Hospitalario de Ourense
2012
University of Buenos Aires
1988
Instituto de Oncología de Rosario
1984
Advanced ovarian cancer treatment comprises cytoreductive surgery followed by chemotherapy. There is no established optimal time between and chemotherapy initiation; however, delays can affect patient survival. Enhanced recovery after (ERAS) programs aim to optimize post-operative may reduce in adjuvant treatment. This study investigated whether the implementation of ERAS protocol reduces for advanced or influences completion planned cycles, evaluated factors causing chemotherapy, examined...
Background/Objectives: An incisional hernia (IH) is a frequent postoperative complication after cytoreductive laparotomic surgery for advanced ovarian cancer (AOC). It occurs in 2–22% of patients the first two years follow-up, depending on series. Although different risk factors have been described various types malignancies and surgeries, few studies analyzed development (OC). However, none examined role enhanced recovery (ERAS) programs. Methods: We performed retrospective study that...
Abstract Supernatants of cultured spleen cells (SCS) from small tumor‐bearing mice (STBM) and large (LTBM) are able to enhance tumor growth as well accelerate takes in vivo when inoculated 24 h before implant. After resection enhancing activity disappears at a rate depending on the size resected tumor. Spleen also evoke complex vascular response, lymphocyte‐induced angiogenesis (LIA) elicited via release lymphokines activated T cells. As angiogenic factors promote development we investigated...
The main objective of this study is to assess the prevalence chromosomal abnormalities in fetuses with cleft lip (CL) and palate (CLP). Secondary objectives were a) isolated CL/CLP those associated anomalies; b) CL versus CLP; c) unilateral, bilateral or central CL/CLP. This an observational single cohort between 2010 2020. population diagnosed CLP, without excluded from analysis. included QF-PCR, karyotype and/or array. result was classified as normal, variant uncertain significance (VUS)...